The effect of tautomycin (TM) on protein kinase C (PKC) was studied in a cell-free system. TM, like phorbol dibutyrate (PDBu), enhanced both base-line and Ca2+/phospholipidsdependent protein kinase activity.
the enzyme for calcium ions (Ca2+), suggesting that TMis a new activator of PKC, distinct from PDBu. In the presence of 10^g/ird phosphatidyl inositol, the activity of PKCreached maximum at 10~3 m Ca2+concentration whenthe other co-factors were absent. Both TMand PDBuincreased the maximumlevel of PKCactivity at the optimum concentration of Ca2+, suggesting that they interacted with the site of PKCwhich is distinct from the site where Ca2+ interacts. TMand PDBudid not activate the enzyme when protamine sulfate in place of histone III-S was used as a substrate, indicating that they activate PKCby affecting the regulatory domain of the enzyme.
Tautomycin (TM) is an antifungal antibiotic, which showed an excellent protective effect against cucumber gray mold in the pot test1}. Wehave found that it induces a characteristic morphological change in humanchronic myeloid leukemia cells (K562), which is similar to that induced by phorbol esters2). Biological activity of phorbol esters is attributed to their activation of protein kinase C (PKC)3~5). TMalso enhanced PKCactivity extracted from K562 cells, in a cell-free system. However, TMdid not induce the differentiation of human promyelocytic leukemia cells (HL-60) and only weakly induced nitroblue-tetrazolium reducing activity in HL-60 cells which had differentiated to mature granulocytes2) ; both these are well-known biological responses of cells induced by phorbol esters6>7). These results suggest that the effect of TMon PKCis different from that of phorbol esters. In this paper, the mode of activation of PKCby TMwas studied in comparison with that by phorbol esters in a cell-free system.
Materials and Methods
PKCwas extracted from K562 cells and partially purified by DEAE-Sephacel (Pharmacia, Uppsala, Sweden) column chromatography, as described previously2). PKC activity was assayed by measuring the phosphate transfer from |j-32P]ATP to histone III-S or protamine sulfate8 and TMwhich was prepared in our laboratory^. Reactions were initiated by the addition of the enzymeand the reaction mixture was incubated at 30°C for 15 minutes. Reactions were terminated by the addition of 200 /A of 20% TCA-1 % PPi to the reaction mixture. The precipitated solutions were filtered on Millipore HAfilters (pore size 0.45^m) and the filters were washed with additional 5 ml of TCA-PPi solution 5 times and counted by a liquid scintillation counter.
Results
PKCactivity is dependent on the concentration of Ca2+ and phospholipid added to the reaction mixture9). In the absence of the co-factors, phosphate transfer was only at background level (Fig. 1) . WhenTMwas added to the reaction mixture, significant increase of the base-line activity, without co factors, was observed. When10~3 m Ca2+ and 20^g/ml PI were added to the reaction mixture, 6,000 cpm of radioactivity was incorporated into the acid-insoluble fraction. The addition of TM over 10^g/ml also enhanced the incorporation. PDBumodulated PKCin the similar fashion to TM. It enhanced both base-line and Ca2+/phospholipid-dependent transfer of phosphate from ATP to histone III-S. Since TMand PDBu induced morphological change of K562 cells over 10^g/ml and 100 ng/ml2'10) respectively, the concentrations required for enhancing the PKC activity in the cell-free system were comparable to those required for the biological activity in the cellular leveL However, a marked difference in the effects of the compoundswas found when suboptimal Ca2+ concentration (10~5 m) was used. In this condition, PDBu (over 100 ng/ml) enhanced the incorporation more remarkably than that in the presence of 10~3 m Ca2+. On the other hand, only an additive incorporation was observed in the case of TM. The result suggested that TMbut not PDBuincreased incorporation independent from Ca2 + concentration.
We, therefore, compared the enhancement of PKCactivity by TMand PDBuas a function of PKC activity was determined as described in Materials and Methods in triplicate assays. Reaction mixture contained TM (A) or PDBu (B), in the absence (à") or presence of Ca2+ 10~3 m (O) or 10 Ca2+ concentration (Fig. 2) . In the presence of 10 /^g/ml PI, maximal incorporation was obtained at 10~3 m Ca2+ whereas the optimal Ca2+ concentration was decreased to 10"6m when 100 ng/ml of PDBuwas added to the reaction mixture. Higher concentration of Ca2+ (10~2 m) rather inhibited the incorporation.
The results were consistent with the conclusion of Castagna et al.^that PDBu enhanced the affinity of the enzyme for Ca2+. WhenTMwas added to the reaction mixture, the Ca2+ concentration re- quired for the maximalincorporation was only slightly affected although the incorporation was enhanced through all the Ca2 + concentrations studied. This suggested that TMincreased the PKC activity without affecting affinity for Ca2+. It should be noted that both PDBuand TMincreased the maximal level of incorporation. The result suggests that TM, like PDBu, interacts with a site of PKCdifferent from that for Ca2+. PKCis composed of two domains; a catalytic domain and a regulatory domain10. PDBuis known to activate PKC by interacting with the regulatory domain12'13). It did not activate the enzymereaction when protamine sulfate was used as a substrate, in place of histone III-S (Table 1) , presumably because protamine sulfate can be phosphorylated in a regulatory domain-independent manner8>9).
H-7 and staurosporine, which inhibit PKC activity by competing with ATP14»15), significantly inhibited the reaction using protamine sulfate as a substrate. TMdid not significantly affect the incorporation in this experiment, suggesting that TMlike PDBuinteract with a regulatory domain ofPKC.
Discussion
Present results suggested that TMenhanced the PKCactivity in a cell-free system by interacting with the regulatory domain. This indicated that TMis a novel activator of PKCwith a mechanism of action distinct from that of phorbol esters. TMmodulates the function of the regulatory domain by interacting with the site other than that for PDBu, because TMdid not activate PKCwhen using protamine sulfate as a substrate and because TMdid not increase the affinity of the enzymefor calcium ions.
Although TMactivated PKCin the cell-free system, it failed to induce the differentiation of promyelocytic leukemia cells. Our experiments revealed that the most marked difference between PDBuand TMwas their effect on the affinity of the enzyme for Ca2+ ; PDBuenhanced the affinity while TMdid not affect significantly. The results suggest that the increase of affinity of the enzyme for Ca2+ is important for the induction of the biological activity of phorbol esters. It has been reported that the differentiation of HL-60 cells is induced by phorbol esters but not by l-oleoyl-2-acetylglycerol (OAG), although OAGcan activate PKCboth in vitro and in vivo16>17\ Therefore, it is possible that some biological activity of phorbol esters, other than activation of PKC, is necessary for the differentiation of HL-60 cells. On the other hand, the morphological change of K562 cells was fully induced by TM2), indicating that only the quantitative activation of PKCis enough for the induction. Further analysis of the mode of protein phosphorylation at molecular level is required for understanding the relationship between induction of the morphological change and PKCactivation. However, it seems likely that 1 293 TM, a new type of modulator of PKC, provides a new basis for explaining biological reactions involving PKC.
